Inventor · disambiguated record
John Knopf
Also filed as: KNOPF JOHN · KNOPF JOHN L
86 granted patents·48 pending applications·1,869 citations·filing 1990–2025
99Inventor score
Top patents by PatentIndex Score
134 records- 0199US10973880B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2020·Granted Apr 13, 2021·7 cites·29 claims
- 0299US8703694B2Methods for increasing thermogenic adipocytesKNOPF JOHN·Filed 2012·Granted Apr 22, 2014·43 cites·42 claims
- 0399US8343933B2Variants derived from ActRIIB and uses thereforACCELERON PHARMA INC·Filed 2010·Granted Jan 1, 2013·91 cites·25 claims
- 0499US8252900B2Actriib-Fc polynucleotides, polypeptides, and compositionsKNOPF JOHN·Filed 2010·Granted Aug 28, 2012·92 cites·5 claims
- 0599US8178488B2Methods for increasing thermogenic adipocytesKNOPF JOHN·Filed 2010·Granted May 15, 2012·92 cites·18 claims
- 0699US7842663B2Variants derived from ActRIIB and uses thereforACCELERON PHARMA INC·Filed 2008·Granted Nov 30, 2010·135 cites·15 claims
- 0799US7709605B2ActRII receptor polypeptides, methods and compositionsACCELERON PHARMA INC·Filed 2005·Granted May 4, 2010·145 cites·29 claims
- 0899US7612041B2Isolated activin-binding ActRIIa polypeptide comprising the SEQ ID NO: 7 and uses for promoting bone growthACCELERON PHARMA INC·Filed 2006·Granted Nov 3, 2009·132 cites·30 claims
- 0998US11219666B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2020·Granted Jan 11, 2022·5 cites·29 claims
- 1098US11065303B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2020·Granted Jul 20, 2021·6 cites·26 claims
- 1198US10946067B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2020·Granted Mar 16, 2021·6 cites·30 claims
- 1298US10722558B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2017·Granted Jul 28, 2020·15 cites·42 claims
- 1398US10695405B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2018·Granted Jun 30, 2020·13 cites·17 claims
- 1498US8629109B2Method for promoting bone growth using activin-actriia antagonistsKNOPF JOHN·Filed 2011·Granted Jan 14, 2014·57 cites·129 claims
- 1598US8128933B2Method of promoting bone growth by an anti-activin B antibodyKNOPF JOHN·Filed 2009·Granted Mar 6, 2012·49 cites·18 claims
- 1698US8067360B2Method for promoting bone growth using activin-ActRIIa antagonistsKNOPF JOHN·Filed 2008·Granted Nov 29, 2011·59 cites·26 claims
- 1798US7951771B2Activin-ActRIIa antagonists and uses for promoting bone growthACCELERON PHARMA INC·Filed 2008·Granted May 31, 2011·56 cites·17 claims
- 1897US10259861B2Variants derived from ActRIIB and uses thereforACCELERON PHARMA INC·Filed 2016·Granted Apr 16, 2019·22 cites·11 claims
- 1997US9353356B2Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumorACCELERON PHARMA INC·Filed 2013·Granted May 31, 2016·36 cites·45 claims
- 2097US8367611B2Activin-actriia antagonists for inhibiting germ cell maturationACCELERON PHARMA INC·Filed 2011·Granted Feb 5, 2013·35 cites·19 claims
- 2197US8173601B2Activin-ActRIIa antagonists and uses for treating multiple myelomaKNOPF JOHN·Filed 2008·Granted May 8, 2012·42 cites·21 claims
- 2297US7960343B2Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretionACCELERON PHARMA INC·Filed 2008·Granted Jun 14, 2011·48 cites·40 claims
- 2397US7501121B2IL-13 binding agentsWYETH CORP·Filed 2005·Granted Mar 10, 2009·112 cites·41 claims
- 2497US6500853B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Dec 31, 2002·104 cites·19 claims
- 2596US11622992B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2020·Granted Apr 11, 2023·3 cites·20 claims
- 2696US9526759B2Activin-actriia antagonists and uses for treating or preventing breast cancerKNOPF JOHN·Filed 2008·Granted Dec 27, 2016·38 cites·34 claims
- 2796US9399669B2Variants derived from ActRIIBACCELERON PHARMA INC·Filed 2012·Granted Jul 26, 2016·27 cites·29 claims
- 2896US9163075B2Isolated polynucleotide that encodes an ActRIIa-Fc fusion polypeptideACCELERON PHARMA INC·Filed 2013·Granted Oct 20, 2015·20 cites·33 claims
- 2996US9138459B2ACTRIIB-FC polynucleotides, polypeptides, and compositionsKNOPF JOHN·Filed 2012·Granted Sep 22, 2015·26 cites·14 claims
- 3093US11028145B2ALK7:actriib heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2019·Granted Jun 8, 2021·4 cites·23 claims
- 3193US9572865B2Activin-actriia antagonists and uses for treating multiple myelomaKNOPF JOHN·Filed 2012·Granted Feb 21, 2017·16 cites·17 claims
- 3293US7807631B2Methods of promoting growth of muscle tissue using ALK7ACCELERON PHARMA INC·Filed 2008·Granted Oct 5, 2010·15 cites·67 claims
- 3392US10071135B2Method of identifying an agent that promotes bone growth or increases bone densityACCELERON PHARMA INC·Filed 2015·Granted Sep 11, 2018·6 cites·12 claims
- 3492US7316998B2Cerberus/Coco derivatives and uses thereofACCELERON PHARMA INC·Filed 2005·Granted Jan 8, 2008·16 cites·21 claims
- 3591US10968282B2Methods for screening compounds for increasing thermogenic adipocytesACCELERON PHARMA INC·Filed 2019·Granted Apr 6, 2021·2 cites·15 claims
- 3691US7456149B2ALK7 and myostatin inhibitors and uses thereofACCELERON PHARMA INC·Filed 2005·Granted Nov 25, 2008·11 cites·4 claims
- 3791US2024358793A1Method for promoting bone growth using activin-actriia antagonistsACCELERON PHARMA INC·Filed 2024·Application pending·0 cites
- 3890US10501547B2ALK7 binding proteins and uses thereofACCELERON PHARMA INC·Filed 2017·Granted Dec 10, 2019·3 cites·7 claims
- 3990US9790284B2Methods for increasing thermogenic adipocytesACCELERON PHARMA INC·Filed 2014·Granted Oct 17, 2017·5 cites·18 claims
- 4089US8642031B2Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereofSEEHRA JASBIR·Filed 2009·Granted Feb 4, 2014·4 cites·13 claims
- 4189US8158584B2Pharmaceutical preparations comprising an ALK1-Fc fusion proteinGRINBERG ASYA·Filed 2009·Granted Apr 17, 2012·10 cites·18 claims
- 4288US8455428B2ALK1 receptor and ligand antagonist and uses thereofGRINBERG ASYA·Filed 2007·Granted Jun 4, 2013·8 cites·21 claims
- 4387US12343378B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2022·Granted Jul 1, 2025·0 cites·61 claims
- 4487US9809636B2Methods for increasing red blood cell levels comprising administering BMP9ACCELERON PHARMA INC·Filed 2013·Granted Nov 7, 2017·8 cites·17 claims
- 4587US8287868B2BMP10 antibodies and related methodsSEEHRA JASBIR·Filed 2008·Granted Oct 16, 2012·6 cites·4 claims
- 4686US10227392B2ALK7:ActRIIB heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2016·Granted Mar 12, 2019·3 cites·29 claims
- 4784US10344066B2Methods and compositions for increasing red blood cellsACCELERON PHARMA INC·Filed 2017·Granted Jul 9, 2019·3 cites·14 claims
- 4884US8486403B2Method of promoting bone growth by an anti-activin A antibodyKNOPF JOHN·Filed 2012·Granted Jul 16, 2013·4 cites·30 claims
- 4984US5322776ADNA sequences encoding phospholipase A2 enzyme and processes for producing enzymeGENETICS INST·Filed 1993·Granted Jun 21, 1994·59 cites·11 claims
- 5084US2024309098A1Alk7 antagonists and uses thereofACCELERON PHARM INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 134 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Knopf files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →